AMOEBA (EPA:ALMIB) | Finanzwire

BRIEF

published on 04/29/2024 at 17:50, 6 months 24 days ago

AMOEBA Announces Filing of Universal Registration Document for 2023

AMOEBA Corporate Governance Universal Registration Document 2023 Financial Report AMF Filing
REGULATED PRESS RELEASE

published on 04/29/2024 at 17:45, 6 months 24 days ago

AMOEBA ANNOUNCES AVAILABILITY OF UNIVERSAL REGISTRATION DOCUMENT 2023
Amoéba announces availability of Universal Registration Document 2023 covering financial year ending on Dec 31, 2023, including annual financial report and corporate governance report

AMOEBA Financial Year Corporate Governance Annual Financial Report Universal Registration Document 2023
BRIEF

published on 04/03/2024 at 17:50, 7 months 20 days ago

AMOEBA announces its capital and the number of voting rights as of March 31, 2024

AMOEBA Voting Rights Capital Biotechnology Sotck Exchange
BRIEF

published on 03/28/2024 at 18:35, 7 months 26 days ago

Amoéba Reports 2023 Earnings: A Transition Year Ahead of Product Launch

AMOEBA Biotech Biocontrol Cosmetics Financial Earnings
REGULATED PRESS RELEASE

published on 03/28/2024 at 18:30, 7 months 26 days ago

Amoéba: 2023 full-year earnings - A year of transition in preparation for the launch of its products
Amoéba reports 2023 full-year earnings, with a focus on biocontrol and cosmetic applications. Financial statements show an improvement in net income despite non-recurring asset impairment

AMOEBA Financial Statements 2023 Earnings Biocontrol Cosmetic Applications
BRIEF

published on 03/12/2024 at 17:50, 8 months 11 days ago

AMOEBA announces its key capital figures for February 2024

AMOEBA Voting Rights Capital Financial Markets Authority February 2024
REGULATED PRESS RELEASE

published on 02/15/2024 at 08:45, 9 months 8 days ago

AMOEBA: Additional information and areas for growth
Amoéba announces strategic focus on biocontrol and cosmetics markets, shift from biocide activity and manufacturing updates, with strong financial support from main shareholder

AMOEBA Manufacturing Financial Support Biocontrol Cosmetics Biocide
REGULATED PRESS RELEASE

published on 02/05/2024 at 08:45, 9 months 18 days ago

AMOEBA: Corporate governance change and review of the company's growth strategy
AMOÉBA changes governance structure and reviews growth strategy. New Chairman and Managing Director appointed. Shift in focus to high-margin products for quicker cash flow. Plant construction put on hold

Growth Strategy AMOEBA Cash Flow Governance Change Chairman Appointment High-margin Products
REGULATED PRESS RELEASE

published on 12/15/2023 at 17:45, 11 months 8 days ago

AMOEBA: Commercial strategy and governance further strengthened and industrial project deferred
REGULATED PRESS RELEASE

published on 10/18/2023 at 17:45, 1 year 1 month ago

AMOEBA: Publication of a scientific paper concerning the efficacy of its biocontrol products to fight tomato late blight and powdery mildews of tomato

Published on 11/22/2024 at 23:55, 1 day 4 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 4 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 5 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 5 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 5 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 10 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 10 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 10 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 11 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 12 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 1 day 13 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 21 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 8 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 10 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 10 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News